Allan Fletcher

Title: Allan Fletcher: Innovator in Pharmacological Research

Introduction

Allan Fletcher is a notable inventor based in Slough, GB. He has made significant contributions to the field of pharmacology, particularly in the development of selective ligands and treatments for cognitive disorders. With a total of 2 patents, his work has had a meaningful impact on medical research and applications.

Latest Patents

Fletcher's latest patents include innovations such as "5-HT.sub.1A ligands - Selective 5-HT.sub.1A antagonists radiolabelled with .sup.3 H or .sup.11 C." These radiolabelled ligands are useful in pharmacological screening procedures and in positron emission tomography (PET) studies. Another significant patent focuses on the "Treatment of cognitive disorders with piperazine derivatives," showcasing his commitment to addressing mental health challenges.

Career Highlights

Allan Fletcher is associated with John Wyeth & Brother Limited, where he has been instrumental in advancing research initiatives. His work at this company has allowed him to explore innovative solutions in pharmacology, contributing to the development of new therapeutic approaches.

Collaborations

Fletcher has collaborated with notable coworkers such as Ian A Cliffe and Alan C White. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Allan Fletcher's contributions to pharmacological research through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence advancements in medical science and treatment methodologies.